Pr Antoine Italiano is the head of the Early Phase Trials and Sarcoma Units at Institut Bergonié (Bordeaux, France) and also head of Precision Medicine at Gustave Roussy (Villejuif, France). Pr Italiano trained as a medical oncologist and obtained the Best Medical Thesis Price from Nice Medical School in 2005.
He gained a PhD degree in Molecular Aspects of Cell Biology in 2008 and completed his training with a post-doctoral fellowship in the laboratory of Cristina Antonescu at Memorial Sloan Kettering Cancer center, New York, USA.
His main research interests are in early clinical development, phase I trials across solid tumors, pharmacodynamic biomarkers, early phase II trials and sarcoma. He is also involved in translational research aspects related to sensitivity and resistance to targeted therapies, notably in soft-tissue sarcoma models. Pr Italiano has been the Principal Investigator of more than 40 phase I trials during the past 5 years as well as a dozen phase II and phase III trials in sarcomas.
Pr Italiano is member of ASCO, AACR, and ESMO. He is peer reviewer for several oncology journals and has contributed to over 200 peer-reviewed publications, including publications as first or last author in the Lancet Oncology, Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.